4
Changes in Ownership
MAIA Biotechnology, Inc. Filed Acc 0001127602-25-014669
Options or other derivatives
- Chief Scientific Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Gryaznov Sergei Chief Scientific Officer | 2025-05-14 | Grant or award · Stock Options | +200,000 | 200,000 | D | ||
Loading xslF345X05/form4.xml…